Phytoestrogens and NAFLD: Possible Mechanisms of Action

被引:7
作者
Li, Hui [1 ]
Jia, Erna [2 ]
Hong, Yu [2 ]
Chen, Yanzhen [2 ]
Jiao, Jian [2 ]
机构
[1] Jilin Univ, China Japan Union Hosp, Dept Dent, Changchun, Peoples R China
[2] Jilin Univ, China Japan Union Hosp, Dept Gastroenterol & Hepatol, Changchun, Peoples R China
关键词
Phytoestrogens; NAFLD; antioxidant; signaling pathway; liver disease; estrogen; FATTY LIVER-DISEASE; DIET-INDUCED OBESITY; NONALCOHOLIC STEATOHEPATITIS; HEPATIC STEATOSIS; O-DESMETHYLANGOLENSIN; OVARIECTOMIZED MICE; REPRODUCTIVE STATUS; INSULIN-RESISTANCE; RISK-FACTOR; GENISTEIN;
D O I
10.2174/1389557520666200103114123
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Nonalcoholic Fatty Liver Disease (NAFLD) includes a variety of changes including nonalcoholic fatty liver, cirrhosis and Hepatocellular Carcinoma (HCC), which are associated with metabolic disorders and cardiovascular diseases. The pathogenesis of NAFLD is complex and multifactorial. Many studies have shown that estrogen has a protective effect on premenopausal women with metabolic disorders and non-alcoholic fatty liver disease. Estrogen supplements may, at least in theory, prevent the development and progression of NAFLD. Phytoestrogen is extracted from plants, especially legumes, whose molecular structure and biological activity are similar to those of mammals estrogen, therefore it could replace the role of estrogen and prevent the occurrence of adverse reactions to estrogen. In this article, we review the published literature related to phytoestrogens and NAFLD as well as suggest the possible mechanisms that may underlie the association between phytoestrogens and NAFLD.
引用
收藏
页码:578 / 583
页数:6
相关论文
共 39 条
  • [1] A polyphenol-rich cranberry extract protects from diet-induced obesity, insulin resistance and intestinal inflammation in association with increased Akkermansia spp. population in the gut microbiota of mice
    Anhe, Fernando F.
    Roy, Denis
    Pilon, Genevieve
    Dudonne, Stephanie
    Matamoros, Sebastien
    Varin, Thibault V.
    Garofalo, Carole
    Moine, Quentin
    Desjardins, Yves
    Levy, Emile
    Marette, Andre
    [J]. GUT, 2015, 64 (06) : 872 - 883
  • [2] NAFLD as a Sexual Dimorphic Disease: Role of Gender and Reproductive Status in the Development and Progression of Nonalcoholic Fatty Liver Disease and Inherent Cardiovascular Risk
    Ballestri, Stefano
    Nascimbeni, Fabio
    Baldelli, Enrica
    Marrazzo, Alessandra
    Romagnoli, Dante
    Lonardo, Amedeo
    [J]. ADVANCES IN THERAPY, 2017, 34 (06) : 1291 - 1326
  • [3] Incidence and risk factors for non-alcoholic steatohepatitis: prospective study of 5408 women enrolled in Italian tamoxifen chemoprevention trial
    Bruno, S
    Maisonneuve, P
    Castellana, P
    Rotmensz, N
    Rossi, S
    Maggioni, M
    Persico, M
    Colombo, A
    Monasterolo, F
    Casadei-Giunchi, D
    Desiderio, F
    Stroffolini, T
    Sacchini, V
    Decensi, A
    Veronesi, U
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2005, 330 (7497): : 932 - 935
  • [4] Estrogen and Microbiota Crosstalk: Should We Pay Attention?
    Chen, Karen L.
    Madak-Erdogan, Zeynep
    [J]. TRENDS IN ENDOCRINOLOGY AND METABOLISM, 2016, 27 (11) : 752 - 755
  • [5] Nonalcoholic fatty liver disease
    Clark, JM
    Brancati, FL
    Diehl, AM
    [J]. GASTROENTEROLOGY, 2002, 122 (06) : 1649 - 1657
  • [6] Obesity prevalence in relation to gut microbial environments capable of producing equol or O-desmethylangolensin from the isoflavone daidzein
    Frankenfeld, C. L.
    Atkinson, C.
    Wahala, K.
    Lampe, J. W.
    [J]. EUROPEAN JOURNAL OF CLINICAL NUTRITION, 2014, 68 (04) : 526 - 530
  • [7] Decreased lipogenesis in white adipose tissue contributes to the resistance to high fat diet-induced obesity in phosphatidylethanolamine N-methyltransferase-deficient mice
    Gao, Xia
    van der Veen, Jelske N.
    Hermansson, Martin
    Ordonez, Marta
    Gomez-Munoz, Antonio
    Vance, Dennis E.
    Jacobs, Rene L.
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS, 2015, 1851 (02): : 152 - 162
  • [8] Prevalence of non alcoholic fatty liver disease in premenopausal, posmenopausal and polycystic ovary syndrome women. The role of estrogens
    Gutierrez Grobe, Ylse
    Ponciano Rodriguez, Guadalupe
    Ramos, Martha H.
    Uribe, Misael
    Mendez Sanchez, Nahum
    [J]. ANNALS OF HEPATOLOGY, 2010, 9 (04) : 402 - 409
  • [9] Aging is a risk factor of nonalcoholic fatty liver disease in premenopausal women
    Hamaguchi, Masahide
    Kojima, Takao
    Ohbora, Akihiro
    Takeda, Noriyuki
    Fukui, Michiaki
    Kato, Takahiro
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2012, 18 (03) : 237 - 243
  • [10] Fatty liver as a risk factor for progression from metabolically healthy to metabolically abnormal in non-overweight individuals
    Hashimoto, Yoshitaka
    Hamaguchi, Masahide
    Fukuda, Takuya
    Ohbora, Akihiro
    Kojima, Takao
    Fukui, Michiaki
    [J]. ENDOCRINE, 2017, 57 (01) : 89 - 97